article thumbnail

M-TEER Reduces Cardiovascular Risk, Improves Quality of Life in HF with Mitral Regurgitation

HCPLive

RESHAPE-HF2 shows mitral transcatheter edge-to-edge repair (M-TEER) reduces heart failure hospitalizations and improves quality of life vs optimal medical therapy alone.

article thumbnail

Novel Tricuspid Valve Procedure Improves Patients' Quality of Life and Health Status

DAIC

For more information: [link] Related Content: Edwards Evoque Transcatheter Tricuspid Valve Replacement System Receives CE Mark Edwards Announces One-year Data on Transfemoral Transcatheter Tricuspid Valve Replacement Six-Month Outcomes Positive for Transfemoral Tricuspid Valve in Tricuspid Regurgitation Patients Edwards LifeSciences Reports (..)

Tricuspid 105
article thumbnail

Comparison of quality of life in patients with mitral valve replacement and mitral valve repair in Imam Ali Hospital during 2014 to 2020: a cross-sectional study

Journal of Cardiothoracic Surgery

Mitral valve failure is one of the most common valvular heart diseases worldwide. Valve replacement and repair have an impact on the quality of life of patients. Therefore, the present study was conducted to c.

article thumbnail

Henry Ford Health Cardiologists Publish Case Series Study on Heart Valve Procedure

DAIC

These key takeaways from the research letter on IVL-facilitated valvuloplasty for severely calcified mitral valve stenosis are published in the Journal of the American College of Cardiology (JACC) Cardiovascular Interventions. We are looking forward to treating patients who have no other options for mitral stenosis diseased valves.”

article thumbnail

Atrium Health Sanger Heart & Vascular Institute Performs Landmark Heart Valve Surgery

DAIC

This can lead to symptoms such as severe shortness of breath, swelling in the legs and abdomen and a significant reduction in quality of life. Nearly 20 years ago, the institute distinguished itself by becoming one of the first centers worldwide to perform the groundbreaking mitral clip procedure as part of an early feasibility study.

article thumbnail

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

Tricuspid regurgitation can put added strain on the heart and lead to other cardiovascular issues, which can significantly worsen a person's quality of life, but historically there have been few treatment options," said Lars Søndergaard , M.D.,

Tricuspid 102
article thumbnail

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve

DAIC

“Edwards has a long history of leading innovation and pioneering new therapies to address the unmet needs of patients with structural heart disease,” said Daveen Chopra , Edwards’ corporate vice president, transcatheter mitral and tricuspid therapies. “We

Tricuspid 100